Press release by SoftGroup

[Press Release] JSC Farmak selects SoftGroup for serialization and aggregation

12th January 2021

 

SoftGroup AD, the best in class end-to-end traceability technology provider in the CEE region, today announced that JSC Farmak, one of the largest Pharmaceutical manufacturers in Ukraine, has selected SoftGroup® SaTT solutions to help its modernization to comply with the Тrack and Тrace regulations within the industry.

 

JSC Farmak is the most innovative company in the pharma industry in Ukraine, and it is the only pharmaceutical company included in the rating of “TOP 25 Innovative Companies of Ukraine”.

 

JSC Farmak is the absolute leader of the Ukrainian pharmaceutical market and the largest exporter of medicinal products since 2010. The 20 GMP-compliant production lines provide high-quality products, exported to more than 20 countries. The company has its substance manufacturing complex (API Production Division) operating in Shostka since 2015 with a planned annual capacity of 100 tons of API.

 

After equipping its packaging lines with machines, Farmak selected the full-stack SoftGroup® SaTT Solution to optimize its capabilities and become fully compliant with Track and Trace compliance by integration with the existing machines, serialization and aggregation hardware, centralized management system, and cloud services for connection with Global Track and Trace system.

 

To learn more about SoftGroup® SaTT solutions and see how SoftGroup provides pharmaceutical companies with outstanding flexibility and the possibility for customization while eliminating the uncertainty of high costs and time-extensive implementations, please contact us.

 

 

CONTACTS

Top

By continuing to use the site, you agree to the terms of our Privacy and Cookies Policy and the use of cookies. Privacy and Cookies Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close